Flagellin from S.typhimurium

This research-grade TLR5 agonist, derived from Salmonella typhimurium flagellin, potently activates immune cells and demonstrates anti-melanoma activity. It is widely used in immunology and oncology research for studying innate immune signaling, cancer cell inhibition, and adjuvant development in both in vitro and in vivo experimental models.